STAT+: Pharmalittle: We’re reading about an FDA commissioner candidate, Germany’s plans for drug prices, and more

Regenxbio plans to apply for accelerated approval for its gene therapy for Duchenne muscular dystrophy.
💡 AI analysis provides alternative perspectives on current events